| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.926 | 0 | 0.926 | Prostaglandin F2 alpha agonist | 0.674 0 DBMET00481 | ||
| 0.893 | 0 | 0.893 | Prostaglandin agonist | 0.817 0 DBMET00481 | ||
| 0.849 | 0.003 | 0.849 | Vasodilator, peripheral | 0.797 0.004 DBMET00481 | ||
| 0.819 | 0.004 | 0.865 | Platelet antagonist | 0.865 0.004 DBMET00481 | DBMET00481 | |
| 0.752 | 0.005 | 0.752 | Antithrombotic | 0.738 0.006 DBMET00481 | ||
| 0.664 | 0.001 | 0.693 | Prostaglandin F2 alpha antagonist | 0.693 0.001 DBMET00481 | DBMET00481 | |
| 0.614 | 0.005 | 0.614 | Vasodilator | 0.611 0.005 DBMET00481 | ||
| 0.596 | 0.002 | 0.654 | Prostaglandin EP2 antagonist | 0.654 0.002 DBMET00481 | DBMET00481 | |
| 0.552 | 0.001 | 0.552 | Prostaglandin E2 agonist | 0.519 0.001 DBMET00481 | ||
| 0.527 | 0.008 | 0.592 | Platelet aggregation inhibitor | 0.592 0.005 DBMET00481 | DBMET00481 | |
| 0.511 | 0.004 | 0.659 | Prostaglandin antagonist | 0.659 0.003 DBMET00481 | DBMET00481 | |
| 0.492 | 0.003 | 0.498 | Gastric antisecretory | 0.498 0.003 DBMET00481 | DBMET00481 | |
| 0.509 | 0.03 | 0.523 | Immunosuppressant | 0.523 0.027 DBMET00481 | DBMET00481 | |
| 0.475 | 0.027 | 0.475 | Spasmolytic | 0.372 0.046 DBMET00481 | ||
| 0.449 | 0.001 | 0.481 | Prostaglandin D2 agonist | 0.481 0.001 DBMET00481 | DBMET00481 | |
| 0.424 | 0.006 | 0.424 | Hemostatic | 0.418 0.007 DBMET00481 | ||
| 0.399 | 0.001 | 0.399 | Prostaglandin EP2 agonist | 0.344 0.001 DBMET00481 | ||
| 0.396 | 0.009 | 0.396 | Protein kinase stimulant | 0.393 0.009 DBMET00481 | ||
| 0.384 | 0.004 | 0.485 | Prostaglandin E2 antagonist | 0.485 0.004 DBMET00481 | DBMET00481 | |
| 0.391 | 0.012 | 0.422 | Platelet adhesion inhibitor | 0.422 0.009 DBMET00481 | DBMET00481 | |
| 0.378 | 0.003 | 0.452 | Prostaglandin EP3 antagonist | 0.452 0.002 DBMET00481 | DBMET00481 | |
| 0.411 | 0.047 | 0.411 | Cholesterol antagonist | 0.401 0.049 DBMET00481 | ||
| 0.377 | 0.015 | 0.377 | Hepatoprotectant | 0.334 0.022 DBMET00481 | ||
| 0.367 | 0.031 | 0.367 | Hypolipemic | 0.314 0.045 DBMET00481 | ||
| 0.382 | 0.055 | 0.382 | Immunostimulant | 0.342 0.067 DBMET00481 | ||
| 0.325 | 0.003 | 0.468 | Prostaglandin EP1 antagonist | 0.468 0.003 DBMET00481 | DBMET00481 | |
| 0.332 | 0.016 | 0.378 | Gastrin inhibitor | 0.378 0.006 DBMET00481 | DBMET00481 | |
| 0.42 | 0.104 | 0.424 | Apoptosis agonist | 0.424 0.103 DBMET00481 | DBMET00481 | |
| 0.368 | 0.054 | 0.368 | Immunomodulator | 0.287 0.09 DBMET00481 | ||
| 0.321 | 0.015 | 0.332 | Bone formation stimulant | 0.332 0.014 DBMET00481 | DBMET00481 | |
| 0.37 | 0.109 | 0.4 | Cyclophilin D inhibitor | 0.4 0.091 DBMET00481 | DBMET00481 | |
| 0.382 | 0.122 | 0.509 | Caspase 9 stimulant | 0.509 0.056 DBMET00481 | DBMET00481 | |
| 0.305 | 0.048 | 0.342 | Angiogenesis stimulant | 0.342 0.035 DBMET00481 | DBMET00481 | |
| 0.254 | 0.003 | 0.443 | Prostaglandin EP4 antagonist | 0.443 0.002 DBMET00481 | DBMET00481 | |
| 0.243 | 0.001 | 0.243 | Prostaglandin EP4 agonist | 0.228 0.001 DBMET00481 | ||
| 0.243 | 0.002 | 0.279 | Prostacyclin agonist | 0.279 0.002 DBMET00481 | DBMET00481 | |
| 0.305 | 0.076 | 0.361 | Caspase 3 stimulant | 0.361 0.056 DBMET00481 | DBMET00481 | |
| 0.23 | 0.003 | 0.424 | Thromboxane antagonist | 0.424 0.002 DBMET00481 | DBMET00481 | |
| 0.283 | 0.059 | 0.283 | Hypoglycemic | 0.246 0.079 DBMET00481 | ||
| 0.294 | 0.078 | 0.362 | Interleukin 2 agonist | 0.362 0.04 DBMET00481 | DBMET00481 | |
| 0.279 | 0.07 | 0.28 | Antioxidant | 0.28 0.07 DBMET00481 | DBMET00481 | |
| 0.221 | 0.015 | 0.221 | Microtubule formation inhibitor | 0.163 0.031 DBMET00481 | ||
| 0.239 | 0.055 | 0.242 | Nitric oxide antagonist | 0.242 0.054 DBMET00481 | DBMET00481 | |
| 0.286 | 0.103 | 0.303 | Transcription factor NF kappa B inhibitor | 0.303 0.093 DBMET00481 | DBMET00481 | |
| 0.28 | 0.1 | 0.311 | Apoptosis antagonist | 0.311 0.078 DBMET00481 | DBMET00481 | |
| 0.207 | 0.027 | 0.22 | Arachidonic acid antagonist | 0.22 0.017 DBMET00481 | DBMET00481 | |
| 0.252 | 0.077 | 0.252 | Interleukin agonist | 0.205 0.116 DBMET00481 | ||
| 0.196 | 0.028 | 0.276 | Cholesterol synthesis inhibitor | 0.276 0.014 DBMET00481 | DBMET00481 | |
| 0.197 | 0.029 | 0.199 | DNA polymerase I inhibitor | 0.199 0.028 DBMET00481 | DBMET00481 | |
| 0.343 | 0.178 | 0.358 | Antiinflammatory | 0.358 0.166 DBMET00481 | DBMET00481 | |
| 0.165 | 0.002 | 0.165 | Nitric oxide donor | 0.164 0.002 DBMET00481 | ||
| 0.201 | 0.04 | 0.241 | NOS3 expression enhancer | 0.241 0.028 DBMET00481 | DBMET00481 | |
| 0.183 | 0.028 | 0.205 | Farnesoid X receptor antagonist | 0.205 0.02 DBMET00481 | DBMET00481 | |
| 0.195 | 0.043 | 0.251 | Interferon gamma antagonist | 0.251 0.028 DBMET00481 | DBMET00481 | |
| 0.212 | 0.062 | 0.212 | Insulin sensitizer | 0.193 0.08 DBMET00481 | ||
| 0.17 | 0.025 | 0.185 | Bronchodilator | 0.185 0.021 DBMET00481 | DBMET00481 | |
| 0.143 | 0.004 | 0.268 | Thromboxane A2 antagonist | 0.268 0.003 DBMET00481 | DBMET00481 | |
| 0.12 | 0.001 | 0.185 | Thromboxane agonist | 0.185 0.001 DBMET00481 | DBMET00481 | |
| 0.248 | 0.13 | 0.328 | Sodium/bile acid cotransporter inhibitor | 0.328 0.055 DBMET00481 | DBMET00481 | |
| 0.173 | 0.058 | 0.21 | Phospholipase A2 inhibitor | 0.21 0.037 DBMET00481 | DBMET00481 | |
| 0.119 | 0.004 | 0.199 | Prostacyclin antagonist | 0.199 0.004 DBMET00481 | DBMET00481 | |
| 0.222 | 0.109 | 0.222 | Transcription factor STAT3 inhibitor | |||
| 0.159 | 0.049 | 0.19 | Adenylate cyclase stimulant | 0.19 0.019 DBMET00481 | DBMET00481 | |
| 0.135 | 0.031 | 0.135 | Toll-Like receptor 4 antagonist | 0.13 0.035 DBMET00481 | ||
| 0.198 | 0.101 | 0.216 | Peptidyltransferase inhibitor | 0.216 0.08 DBMET00481 | DBMET00481 | |
| 0.161 | 0.068 | 0.181 | Melanin inhibitor | 0.181 0.051 DBMET00481 | DBMET00481 | |
| 0.111 | 0.018 | 0.159 | Leukotriene antagonist | 0.159 0.009 DBMET00481 | DBMET00481 | |
| 0.121 | 0.03 | 0.132 | ABCA1 expression enhancer | 0.132 0.024 DBMET00481 | DBMET00481 | |
| 0.145 | 0.056 | 0.145 | Toll-Like receptor 2 antagonist | 0.102 0.101 DBMET00481 | ||
| 0.113 | 0.025 | 0.117 | ATPase (Vacuolar H+) inhibitor | 0.117 0.022 DBMET00481 | DBMET00481 | |
| 0.112 | 0.03 | 0.112 | Transcription factor NF kappa B stimulant | 0.099 0.04 DBMET00481 | ||
| 0.097 | 0.029 | 0.104 | Peroxisome proliferator-activated receptor gamma agonist | 0.104 0.026 DBMET00481 | DBMET00481 | |
| 0.137 | 0.071 | 0.167 | Neurotrophic factor | 0.167 0.046 DBMET00481 | DBMET00481 | |
| 0.09 | 0.026 | 0.09 | Elastase 1 inhibitor | 0.068 0.05 DBMET00481 | ||
| 0.093 | 0.038 | 0.098 | Na+ K+ transporting ATPase inhibitor | 0.098 0.033 DBMET00481 | DBMET00481 | |
| 0.051 | 0.004 | 0.052 | Calcium-independent phospholipase A2 inhibitor | 0.052 0.004 DBMET00481 | DBMET00481 | |
| 0.099 | 0.052 | 0.102 | Bile acid receptor antagonist | 0.102 0.045 DBMET00481 | DBMET00481 | |
| 0.067 | 0.022 | 0.109 | Leukotriene B4 antagonist | 0.109 0.009 DBMET00481 | DBMET00481 | |
| 0.102 | 0.059 | 0.124 | Anabolic | 0.124 0.036 DBMET00481 | DBMET00481 | |
| 0.153 | 0.112 | 0.153 | P-glycoprotein inhibitor | |||
| 0.056 | 0.02 | 0.056 | Microtubule stabilization | 0.044 0.035 DBMET00481 | ||
| 0.087 | 0.052 | 0.087 | Antineoplastic antibiotic | 0.082 0.056 DBMET00481 | ||
| 0.109 | 0.075 | 0.109 | Anesthetic local | |||
| 0.146 | 0.114 | 0.199 | Phospholipase C inhibitor | 0.199 0.045 DBMET00481 | DBMET00481 | |
| 0.062 | 0.031 | 0.064 | Lipocortins synthesis agonist | 0.064 0.028 DBMET00481 | DBMET00481 | |
| 0.061 | 0.03 | 0.061 | Protein 50S ribosomal subunit inhibitor | 0.059 0.031 DBMET00481 | ||
| 0.033 | 0.003 | 0.061 | Thromboxane A2 agonist | 0.061 0.002 DBMET00481 | DBMET00481 | |
| 0.038 | 0.009 | 0.091 | Prostaglandin D2 antagonist | 0.091 0.005 DBMET00481 | DBMET00481 | |
| 0.042 | 0.013 | 0.043 | HMG CoA reductase inhibitor | 0.043 0.012 DBMET00481 | DBMET00481 | |
| 0.086 | 0.061 | 0.112 | Ornithine decarboxylase inhibitor | 0.112 0.032 DBMET00481 | DBMET00481 | |
| 0.053 | 0.03 | 0.053 | Peroxisome proliferator-activated receptor alpha agonist | 0.045 0.036 DBMET00481 | ||
| 0.027 | 0.004 | 0.03 | Vitamin D receptor agonist | 0.03 0.004 DBMET00481 | DBMET00481 | |
| 0.128 | 0.107 | 0.17 | Hexokinase inhibitor | 0.17 0.058 DBMET00481 | DBMET00481 | |
| 0.038 | 0.019 | 0.038 | Squalene synthetase inhibitor | |||
| 0.082 | 0.065 | 0.087 | Vanilloid agonist | 0.087 0.054 DBMET00481 | DBMET00481 | |
| 0.026 | 0.009 | 0.027 | Vitamin D receptor antagonist | 0.027 0.009 DBMET00481 | DBMET00481 | |
| 0.153 | 0.141 | 0.155 | Free radical scavenger | 0.155 0.139 DBMET00481 | DBMET00481 | |
| 0.03 | 0.023 | 0.03 | Elastase 2B inhibitor | |||
| 0.03 | 0.023 | 0.03 | Elastase 3A inhibitor | |||
| 0.03 | 0.023 | 0.03 | Elastase 3B inhibitor | |||
| 0.013 | 0.006 | 0.013 | Calcineurin inhibitor | 0.013 0.006 DBMET00481 | ||
| 0.025 | 0.018 | 0.051 | Prostaglandin H2 antagonist | 0.051 0.004 DBMET00481 | DBMET00481 | |
| 0.112 | 0.108 | 0.126 | Vanilloid 1 agonist | 0.126 0.075 DBMET00481 | DBMET00481 | |
| 0.084 | 0.083 | 0.084 | Lanosterol 14 alpha demethylase inhibitor | |||
| 0.133 | 0.135 | 0.171 | ATPase inhibitor | 0.171 0.07 DBMET00481 | DBMET00481 | |
| 0.01 | 0.012 | 0.011 | Calcium-dependent phospholipase A2 inhibitor | 0.011 0.01 DBMET00481 | DBMET00481 | |
| 0.041 | 0.045 | 0.047 | Parathyroid hormone antagonist | 0.047 0.026 DBMET00481 | DBMET00481 | |
| 0.018 | 0.023 | 0.021 | Lysophosphatidic acid 1 receptor antagonist | 0.021 0.016 DBMET00481 | DBMET00481 | |
| 0.131 | 0.137 | 0.182 | Lipocortins synthesis antagonist | 0.182 0.069 DBMET00481 | DBMET00481 | |
| 0.117 | 0.127 | 0.173 | Growth hormone agonist | 0.173 0.071 DBMET00481 | DBMET00481 | |
| 0.017 | 0.027 | 0.025 | Leukotriene B4 receptor 2 antagonist | 0.025 0.012 DBMET00481 | DBMET00481 | |
| 0.023 | 0.033 | 0.029 | Retinoid X gamma receptor antagonist | 0.029 0.014 DBMET00481 | DBMET00481 | |
| 0.046 | 0.059 | 0.071 | Thromboxane synthase inhibitor | 0.071 0.017 DBMET00481 | DBMET00481 | |
| 0.05 | 0.068 | 0.064 | Leukotriene C antagonist | 0.064 0.021 DBMET00481 | DBMET00481 | |
| 0.016 | 0.038 | 0.035 | Leukotriene B4 receptor 1 antagonist | 0.035 0.015 DBMET00481 | DBMET00481 | |
| 0.093 | 0.117 | 0.103 | Estrogen antagonist | 0.103 0.092 DBMET00481 | DBMET00481 | |
| 0.032 | 0.064 | 0.042 | Leukotriene C4 antagonist | 0.042 0.019 DBMET00481 | DBMET00481 | |
| 0.036 | 0.069 | 0.059 | Glucose-6-phosphate isomerase inhibitor | 0.059 0.019 DBMET00481 | DBMET00481 | |
| 0.124 | 0.159 | 0.135 | Ca2+-transporting ATPase inhibitor | 0.135 0.093 DBMET00481 | DBMET00481 | |
| 0.118 | 0.154 | 0.156 | Anesthetic general | 0.156 0.108 DBMET00481 | DBMET00481 | |
| 0.073 | 0.143 | 0.113 | Adenylate kinase inhibitor | 0.113 0.05 DBMET00481 | DBMET00481 | |
| 0.037 | 0.108 | 0.059 | Leukotriene synthesis inhibitor | 0.059 0.057 DBMET00481 | DBMET00481 | |
| 0.056 | 0.154 | 0.086 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.086 0.072 DBMET00481 | DBMET00481 | |
| 0.028 | 0.127 | 0.08 | Phosphofructokinase-1 inhibitor | 0.08 0.041 DBMET00481 | DBMET00481 | |
| 0.047 | 0.151 | 0.074 | Keratolytic | 0.074 0.058 DBMET00481 | DBMET00481 | |
| 0.025 | 0.147 | 0.053 | Aconitate hydratase inhibitor | 0.053 0.034 DBMET00481 | DBMET00481 | |
| 0.064 | 0.19 | 0.125 | Thrombolytic | 0.125 0.105 DBMET00481 | DBMET00481 | |
| 0.026 | 0.365 | 0.088 | GABA C receptor agonist | 0.088 0.082 DBMET00481 | DBMET00481 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |